.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The U.S. Food and Drug Administration (FDA) has cleared the first OTC glucose monitor for pediatric use. Specifically, the regulatory agency expanded the authorization of Dexcom's Stelo Glucose Biosensor System. Consequently, the device is now available for children aged two years and older who do not use insulin. Previously, the FDA approved Stelo only for adults aged 18 and older in March 2024. Therefore, this decision marks a significant milestone in accessible pediatric healthcare.
The Stelo system uses a wearable sensor and a smartphone app to measure glucose levels. Furthermore, the device updates readings and tracks trends every 15 minutes. Each sensor lasts up to 15 days under normal conditions. However, the FDA noted that sensor wear time may be shorter in children due to physiological and behavioral reasons. Consequently, parents must monitor the adhesive and placement of the sensor regularly.
This device helps children and their caregivers understand how lifestyle choices affect blood sugar. Specifically, it reveals the immediate impacts of meals, exercise, and daily routines. Importantly, pediatric patients must use this device under direct adult supervision. Healthcare providers should advise parents to consult a professional before altering any medications. Moreover, the device is not suitable for individuals with problematic low blood sugar because it lacks hypoglycemia alerts.
Q1: Who is eligible to use the pediatric Dexcom Stelo system?
The device is cleared for children aged two years and older who do not use insulin.
Q2: Does the Stelo glucose monitor alert users about low blood sugar?
No. The device does not alert users about problematic low blood sugar.
Q3: How long does each Stelo sensor last?
Each sensor lasts up to 15 days. However, pediatric wear time may be shorter.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FDA has cleared Dexcom's Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitor for pediatric use. The device is approved for children aged two and older who do not use insulin, helping caregivers track real-time glucose trends.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
